EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more
EKF Diagnostics Holdings plc (EKDHF) - Net Assets
Latest net assets as of June 2025: $72.88 Million USD
Based on the latest financial reports, EKF Diagnostics Holdings plc (EKDHF) has net assets worth $72.88 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($82.43 Million) and total liabilities ($9.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $72.88 Million |
| % of Total Assets | 88.41% |
| Annual Growth Rate | 28.88% |
| 5-Year Change | -6.38% |
| 10-Year Change | 56.59% |
| Growth Volatility | 260.0 |
EKF Diagnostics Holdings plc - Net Assets Trend (2001–2024)
This chart illustrates how EKF Diagnostics Holdings plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EKF Diagnostics Holdings plc (2001–2024)
The table below shows the annual net assets of EKF Diagnostics Holdings plc from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $73.21 Million | +7.32% |
| 2023-12-31 | $68.22 Million | -8.46% |
| 2022-12-31 | $74.52 Million | -21.34% |
| 2021-12-31 | $94.74 Million | +21.15% |
| 2020-12-31 | $78.20 Million | +9.87% |
| 2019-12-31 | $71.17 Million | +11.37% |
| 2018-12-31 | $63.90 Million | +5.63% |
| 2017-12-31 | $60.50 Million | -0.78% |
| 2016-12-31 | $60.97 Million | +30.41% |
| 2015-12-31 | $46.75 Million | -46.49% |
| 2014-12-31 | $87.38 Million | +113.52% |
| 2013-12-31 | $40.92 Million | +3.79% |
| 2012-12-31 | $39.43 Million | +5.34% |
| 2011-12-31 | $37.43 Million | +59.07% |
| 2010-12-31 | $23.53 Million | +318.67% |
| 2009-12-31 | $5.62 Million | +10.85% |
| 2008-12-31 | $5.07 Million | +1.89% |
| 2007-12-31 | $4.98 Million | +15.75% |
| 2006-12-31 | $4.30 Million | +15.75% |
| 2005-12-31 | $3.71 Million | +19.23% |
| 2004-12-31 | $3.12 Million | +26.73% |
| 2003-12-31 | $2.46 Million | -15.30% |
| 2002-12-31 | $2.90 Million | +1256.07% |
| 2001-12-31 | $214.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EKF Diagnostics Holdings plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 31691.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $55.00 Million | 76.04% |
| Common Stock | $4.54 Million | 6.27% |
| Other Comprehensive Income | $6.76 Million | 9.35% |
| Other Components | $6.03 Million | 8.34% |
| Total Equity | $72.33 Million | 100.00% |
EKF Diagnostics Holdings plc Competitors by Market Cap
The table below lists competitors of EKF Diagnostics Holdings plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Theratechnologies Inc.
NASDAQ:THTX
|
$129.60 Million |
|
Hebei Keli Automobile Equipment Co., Ltd.
SHE:301552
|
$129.65 Million |
|
Track & Field Co S.A
SA:TFCO4
|
$129.69 Million |
|
Guangzhou Jinyi Media Corp
SHE:002905
|
$129.74 Million |
|
Innova Captab Limited
NSE:INNOVACAP
|
$129.48 Million |
|
Hanil Cement Co Ltd
KO:003300
|
$129.47 Million |
|
CVC Brasil Operadora e Agencia
SA:CVCB3
|
$129.40 Million |
|
Curiositystream Inc.
NASDAQ:CURI
|
$129.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EKF Diagnostics Holdings plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 67,117,000 to 72,327,000, a change of 5,210,000 (7.8%).
- Net income of 6,242,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 324,944.
- Other factors decreased equity by 1,356,944.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.24 Million | +8.63% |
| Other Comprehensive Income | $324.94K | +0.45% |
| Other Changes | $-1.36 Million | -1.88% |
| Total Change | $- | 7.76% |
Book Value vs Market Value Analysis
This analysis compares EKF Diagnostics Holdings plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.23x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 244.47x to 2.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $0.00 | $0.36 | x |
| 2002-12-31 | $0.03 | $0.36 | x |
| 2003-12-31 | $0.09 | $0.36 | x |
| 2004-12-31 | $0.09 | $0.36 | x |
| 2005-12-31 | $0.11 | $0.36 | x |
| 2006-12-31 | $0.13 | $0.36 | x |
| 2007-12-31 | $0.15 | $0.36 | x |
| 2008-12-31 | $0.15 | $0.36 | x |
| 2009-12-31 | $0.16 | $0.36 | x |
| 2010-12-31 | $0.24 | $0.36 | x |
| 2011-12-31 | $0.17 | $0.36 | x |
| 2012-12-31 | $0.14 | $0.36 | x |
| 2013-12-31 | $0.14 | $0.36 | x |
| 2014-12-31 | $0.22 | $0.36 | x |
| 2015-12-31 | $0.11 | $0.36 | x |
| 2016-12-31 | $0.13 | $0.36 | x |
| 2017-12-31 | $0.13 | $0.36 | x |
| 2018-12-31 | $0.14 | $0.36 | x |
| 2019-12-31 | $0.15 | $0.36 | x |
| 2020-12-31 | $0.17 | $0.36 | x |
| 2021-12-31 | $0.20 | $0.36 | x |
| 2022-12-31 | $0.16 | $0.36 | x |
| 2023-12-31 | $0.15 | $0.36 | x |
| 2024-12-31 | $0.16 | $0.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EKF Diagnostics Holdings plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.63%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.44%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.13x
- Recent ROE (8.63%) is above the historical average (2.81%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 137.38% | 26.82% | 0.20x | 25.46x | $272.60K |
| 2002 | 4.93% | 8.85% | 0.25x | 2.22x | $-147.20K |
| 2003 | -19.32% | -37.25% | 0.20x | 2.57x | $-720.80K |
| 2004 | -18.91% | -26.35% | 0.34x | 2.14x | $-900.50K |
| 2005 | 20.81% | 23.70% | 0.67x | 1.30x | $401.60K |
| 2006 | 13.86% | 19.37% | 0.60x | 1.20x | $166.10K |
| 2007 | 9.34% | 136.36% | 0.06x | 1.12x | $-32.60K |
| 2008 | -25.78% | -281.08% | 0.08x | 1.13x | $-1.81 Million |
| 2009 | -3.61% | 0.00% | 0.00x | 1.14x | $-765.00K |
| 2010 | -14.79% | -52.98% | 0.18x | 1.55x | $-5.76 Million |
| 2011 | -7.79% | -13.32% | 0.37x | 1.59x | $-6.59 Million |
| 2012 | 4.70% | 7.02% | 0.47x | 1.43x | $-2.06 Million |
| 2013 | -2.79% | -3.54% | 0.52x | 1.50x | $-5.17 Million |
| 2014 | -6.54% | -14.20% | 0.30x | 1.56x | $-14.39 Million |
| 2015 | -79.85% | -123.56% | 0.42x | 1.55x | $-41.77 Million |
| 2016 | -0.03% | -0.05% | 0.47x | 1.36x | $-6.06 Million |
| 2017 | 4.53% | 6.53% | 0.54x | 1.29x | $-3.28 Million |
| 2018 | 15.91% | 23.76% | 0.52x | 1.28x | $3.76 Million |
| 2019 | 5.21% | 8.19% | 0.52x | 1.23x | $-3.38 Million |
| 2020 | 14.31% | 17.03% | 0.64x | 1.30x | $3.35 Million |
| 2021 | 16.84% | 19.37% | 0.71x | 1.22x | $6.44 Million |
| 2022 | -13.06% | -14.37% | 0.75x | 1.22x | $-16.91 Million |
| 2023 | 3.50% | 4.47% | 0.65x | 1.20x | $-4.36 Million |
| 2024 | 8.63% | 12.44% | 0.61x | 1.13x | $-990.70K |
Industry Comparison
This section compares EKF Diagnostics Holdings plc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $498,972,584
- Average return on equity (ROE) among peers: -54.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EKF Diagnostics Holdings plc (EKDHF) | $72.88 Million | 137.38% | 0.13x | $129.58 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-2.23 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $187.53 Billion |
| Acarix AB (publ) (ACIXF) | $51.88 Million | -150.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $3.82 Million |
| Adm Tronics Unltd (ADMT) | $644.00K | 0.00% | 0.66x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $732.88K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $916.00 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $8.41 Million |